Volume 28, Number 6—June 2022
Research
Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease
Table 3
Measure |
Measure, % (95% CI) |
|||||
Sensitivity |
Specificity |
PPV |
NPV |
LR+ |
LR– |
|
Score | ||||||
>0 | 98.3 (94.1–99.8) | 26.2 (21.9–30.8) | 28.5 (24.2–33.1) | 98.1 (93.4–99.8) | 1.33 (1.25–1.42) | 0.06 (0.02–0.25) |
>1 | 95.8 (90.5–98.6) | 52.4 (47.3–57.3) | 37.6 (32.1–43.3) | 97.7 (94.7–99.2) | 2.01 (1.8–2.24) | 0.08 (0.03–0.19) |
>2 | 94.2 (88.4–97.6) | 60.1 (55.1–64.9) | 41.4 (35.5–47.5) | 97.2 (94.3–98.9) | 2.36 (2.08–2.68) | 0.10 (0.05–0.2) |
>3 | 79.2 (70.8–86.0) | 81.8 (77.7–85.4) | 56.6 (48.7–64.2) | 92.9 (89.7–95.4) | 4.35 (3.47–5.46) | 0.25 (0.18–0.36) |
>4 |
26.7 (19.0–35.5) |
98.0 (96.1–99.1) |
80.0 (64.4–90.9) |
81.7 (78.0–85.1) |
13.4 (6.33–28.2) |
0.75 (0.67–0.83) |
WHO criteria | 83.3 (75.4–89.5) | 28.9 (24.5–33.6) | 26.0 (21.7–30.7) | 85.3 (78.2–90.8) | 1.17 (1.06–1.30) | 0.58 (0.38–0.88) |
*LR+, true positive/false positive likelihood ratio; LR–, false negative/true negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; WHO, World Health Organization.
1These authors contributed equally to this article.
2These authors contributed equally to this article.
3Current affiliation: Pediatric Infectious Diseases & Immunology, Connecticut Children’s Medical Center, Hartford, Connecticut, USA.
Page created: April 11, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.